A transformational milestone in Brazil: Diaverum expands its presence through landmark acquisition

Diaverum, the global leader in renal care and part of the M42 group, has completed a strategic acquisition in the state of São Paulo, significantly strengthening its platform in Latin America’s largest healthcare market. The transaction further scales Diaverum’s presence through a combination of clinic operations, management contracts and acute services, reinforcing its commitment to advancing its long-term growth agenda in Brazil. The acquisition includes four established clinics within the Lund Group  - CDTR and CDTR Prime in Sorocaba,

Diaverum opens one of the largest dialysis centres in Germany

Diaverum has expanded its operations in Germany, with the opening of a major new clinic in Hamburg, currently one of the largest dialysis centres in the country. The new clinic will provide care to more than 350 patients who were previously treated at Diaverum’s Alter Teichweg and Wandsbek clinics, both of which have now permanently closed. Located on Am Stadtrand in Hamburg’s Wandsbek district, the most populous district of Hamburg with over 420,000 residents, the facility features state-of-the-art medical technology and modern infrastructure. It includes four dialysis areas

Diaverum expands in Chile with three new clinics in the Valparaíso region

Diaverum has completed the acquisition of three new clinics located in the Valparaíso region in central Chile. This expansion strengthens the organisation’s national growth strategy by broadening access to high-quality renal care in one of the country’s key economic hubs, renowned for its healthcare, tourism, and education sectors.Through the acquisition of these clinics, Diaverum will expand its presence across two major urban centres – Valparaíso and Viña del Mar. Together, these cities have a combined population of approximately 700,000 inhabitants. Diaverum will provide outpatient

Diaverum expands its Spanish network with new operations in Andalusia

Diaverum has been awarded a retender and expansion contract to deliver outpatient haemodialysis services in the province of Jaén, located in Andalusia in southern Spain, for the next five years.The new contract will allow the company to strengthen its presence in Jaén - where it already operates one clinic and will now add two new one - and further consolidate its long-standing presence across Andalusia, where it has been delivering renal care for more than 40 years. Diaverum opened its first clinic in Torremolinos (Málaga) - the birthplace of Diaverum’s d.HOLIDAY 

Diaverum grows its footprint in Brazil

Diaverum, the Swedish-born, global renal care provider, today announced that it has completed the acquisition of Serviço de Nefrologia Ribeirão Preto (SENERP) – a dialysis clinic located in Ribeirão Preto, a city in the northeastern part of São Paulo state. This expansion strengthens the company's growth strategy in Brazil by broadening access to high-quality renal care in one of the country’s most economically active and dynamic regions.SENERP is operated by renowned nephrologists and has recently undergone a major refurbishment and expansion, increasing its treatment capacity and

Diaverum secures major contract to provide life-enhancing renal care in Córdoba, Spain

Diaverum, the Swedish-born, global renal care provider, today announced that it has been awarded a five-year contract to deliver out-of-hospital haemodialysis services in the province of Córdoba. This important milestone marks the latest step in the company's strategic expansion and reaffirms its commitment to delivering world-class, patient-centred renal care across Spain.Under the new contract, Diaverum will serve more than 360 patients in Córdoba whose reference hospital is the Reina Sofía University Hospital. To provide these services, it will build four new dialysis clinics, with

Diaverum strengthens its presence in Portugal's central region, through acquisition of Nefropinhal clinic in Sertã

Malmö, Sweden, 15 July 2025 – Diaverum, the Swedish-born global renal care provider, today announced the completion of its latest clinic aquisition in Portugal. Located in Sertã, approximately two hours northeast of Lisbon, this clinic will strengthen the company’s presence in Portugal’s central region, furthering its mission to provide life-enhancing renal care in the country.With infrastructure already in place to operate 20 dialysis machines, the new clinic has capacity to scale its operations and treat up to 120 patients, supported by a multidisciplinary team comprised of nephrologists,

Delivering life-enhancing renal care responsibly: Diaverum releases its 2024 ESG report

Malmö, Sweden, 24 June 2025 – Diaverum, the Swedish-born global renal care provider, today announced the release of its 2024 Environmental, Social and Governance (ESG) Report. The report includes information related to the company’s non-financial performance last year and underscores how its mission to deliver life-enhancing renal care is intrinsically linked to its commitment to ESG excellence.2024 marked a pivotal chapter as Diaverum integrated further with M42, its strategic investor, joining its newly created Global Patient Care 

Diaverum expands network with new dialysis clinic in São Paulo

Malmö, Sweden, 19 June 2025 – Diaverum, the Swedish-born global renal care provider, today announced its acquisition of UNTR clinic, located in Santana de Parnaíba in the São Paulo metropolitan region. This marks the company’s second acquisition in São Paulo in less than a year, in addition to the opening of its clinic in Aracaju, Sergipe.The new clinic currently operates 37 dialysis machines, serving approximately 180 chronic kidney disease (CKD) patients under Brazil’s public healthcare system (Sistema Único de Saúde - SUS). Its core service is haemodialysis, complemented by comprehensive

Diaverum acquires new dialysis clinic in Kuala Lumpur

Malmö, 27 May 2025 -  Diaverum, the Swedish-born global renal care provider, today announced that it has successfully acquired full ownership of IMU Dialysis Sdn Bhd in Kuala Lumpur, effective March 2025. In line with this development, the clinic has been officially renamed Diaverum Renal Services Sdn Bhd.Located in Bandar Baru Sri Petaling, a suburb in the southern part of Kuala Lumpur, the clinic offers comprehensive dialysis treatment with 12 dialysis stations, capable of treating up to 72 patients. Its main services focus on the provision of haemodialysis, along with the coordination

Diaverum appoints Rafael Romanini as Group CEO

Sweden, 6 May 2025 – Diaverum, the Swedish-born global renal care provider, today announced the appointment of Rafael Romanini as its new Chief Executive Officer, effective immediately. This follows the appointment of Dimitris Moulavasilis as Group CEO of M42, Diaverum’s strategic investor, which acquired the company in 2023. Mr. Moulavasilis will work closely with Mr. Romanini over the coming weeks to ensure a seamless transition.Since joining Diaverum in 2018 as Country Manager for Brazil, Mr. Romanini has demonstrated outstanding leadership in driving operational excellence, expanding

Diaverum Germany strengthens renal care network with acquisition of two clinics

Diaverum Germany is expanding its provision of life-enhancing renal care with the acquisition of two new clinics, bringing its current footprint to 18 clinics in the country.Chronic kidney disease (CKD) is a significant health concern in Germany with the prevalence of diagnosed CKD increasing over the years. Efforts to improve early detection, management and the treatment of CKD are essential to address this growing health concern.  As part of Diaverum’s mission to expand access to life-enhancing renal care worldwide, Diaverum Germany has acquired two dialysis centres in Neubrandenburg

Diaverum announces market entry in the UAE, with planned investments in the cities of Abu Dhabi and Al-Ain

Diaverum is honoured to announce its plans to commence operations in the cities of Abu Dhabi and Al-Ain, in the United Arab Emirates (UAE). This news follows Diaverum’s acquisition by M42 , the global health leader powered by AI and technology, that is building a network of world-class health providers to  disrupt traditional healthcare models, and positively impact lives worldwide.As a Swedish-born, global leader in renal care, Diaverum has a presence in 24 countries, with 13,500 healthcare

Diaverum expands its reach in Greece, through strategic partnership with BIOIATRIKI Healthcare Group

The Sweden-based, global renal care provider Diaverum is delighted to announce its further expansion into Greece, having entered into a strategic partnership with the renowned provider, BIOIATRIKI Healthcare Group.Earlier this year, Diaverum announced its vision to transform renal care in Greece . Having already acquired six clinics, the company has established a significant presence in the country, positioning itself as the third-largest provider in the dialysis care sector.

Diaverum expands provision of life-enhancing renal care in Brazil

Diaverum, the Swedish-born, global renal care provider, is pleased to announce that it is expanding its presence in Brazil with two new clinics. Its de novo reference clinic in Sergipe, standing proud as one of the largest dialysis centres in the country, along with its acquired clinic in São Paulo, offering comprehensive multidisciplinary care, will enable it to significantly increase access to life-enhancing renal care across the country.Since entering Brazil in 2017, Diaverum has been ambitiously expanding its presence across the country. The newly acquired clinic in São Paulo will

Diaverum wins new tender to provide renal care services in Birmingham

Diaverum, the Swedish-born, global renal care provider, is pleased to announce that it has been awarded a significant new contract to supply life-enhancing renal care in Woodgate, Birmingham.The contract, which was awarded in January 2024, came through a University Hospitals Birmingham NHS Foundation Trust tender. It encompasses the provision of fully managed services - including nursing, consumables, equipment, facilities, pharmaceuticals and nutrition services - at the Woodgate Dialysis Unit for the next 12 years.  The Woodgate Dialysis Unit currently includes 24 dialysis stations

Diaverum supports patients on kidney transplantation lists to travel with its d.HOLIDAY Fly Back programme

Diaverum, the Sweden-based, global renal care provider, has today announced that its leading holiday dialysis programme, d.HOLIDAY, will be facilitating and funding safe & fast returns home for holiday dialysis patients who may receive their long-awaited transplant call whilst travelling within Europe.The d.HOLIDAY Fly Back programme is set to address a key concern for many eligible kidney transplantation patients, that can severely curtail their mobility and freedom of movement – that is, what should happen if they get the call from their transplantation coordinator whilst being away from

Tackling the climate crisis by focusing on the patient: Diaverum releases its 2023 ESG report

Diaverum, the Swedish-born, multinational healthcare organisation has today released its 2023 Environmental, Social and Governance (ESG) Report. Alongside information related to the company’s non-financial performance last year, the report shows how Diaverum is tackling the environmental impact of its operations head on, with sustainability and climate change as top priorities moving forward. It also articulates its new environmental strategy to lead Diaverum to Net Zero by 2050, firmly rooted in the understanding that focus on patient care is also good for the planet.As a leading

Diaverum wins major tender to provide renal care services in South West England

Diaverum, the Swedish-born, global renal care provider, is pleased to announce that it has been awarded a significant new contract to supply life-enhancing renal care in South West England.The tender, which was submitted in September 2023, came through the Gloucestershire NHS Foundations Trust Tender for ‘The Provision of a Renal Dialysis Managed Service’. It encompasses the units of Cotswolds, Severn and Ward B, which are located in Gloucester NHS Hospital, as well as the Forest Unit in Cinderford.  This announcement marks Diaverum’s further expansion into South West England, where it

d.HOLIDAY: Diaverum's holiday dialysis programme launches in Greece

Diaverum, the Sweden-based, global renal care provider is excited to announce that its leading holiday dialysis programme is now available in Greece, one of the world’s most popular travel destinations. With d.HOLIDAY, dialysis patients will be able to enjoy holidays in the country, or travel domestically to see friends and family, with the assurance that they can continue their treatment while on the go, in line with Diaverum's benchmark standards of care.This news comes shortly after the announcement of Diaverum’s entry into the Greek market in January 

Diaverum announces Greece entry as the country’s third largest dialysis provider

The Sweden-based, global renal care provider Diaverum is today delighted to announce it is entering Greece, with a network of six clinics across the country. The company has ambitious growth plans to become Greece’s leading provider of integrated, AI-enabled, personalised dialysis care and a global, attractive hub for holiday dialysis treatments.With the acquisition of six clinics in Attica and the neighbouring Boetia and Euboea regions, Diaverum has positioned itself as the third largest renal care provider in Greece. The newly acquired clinics of Medifil, Alexia, Attiko and Nefrologiki

Diaverum’s 2022 report shows how the company is accelerating its ESG agenda

Diaverum, the Swedish-born, multinational healthcare organisation has today released its 2022 Environmental, Social and Governance (ESG) Report. Alongside information related to the company’s non-financial performance last year, the report shows how Diaverum’s focus on driving forward its ESG agenda has grown in importance and scale, particularly in light of the events that have played a dominant role on the world stage over the past three years -  the global pandemic, the war in Ukraine and the resulting economic recession.The societal and economic challenges that these combined events

Diaverum and Nipro seal long-term and mutually value-adding partnership

On 24 April, a delegation from Diaverum led by the company’s CEO, Mr. Dimitris Moulavasilis, met with Nipro’s President, Mr. Yoshihiko Sano, at the new Nipro Corporation Japan headquarters in Osaka, Japan, to mark the signing and official commencement of a prolonged partnership between the parties.Diaverum and Nipro are committed to further strengthening ties and exploring long-term opportunities for continued and diversified collaboration in many areas, reinforcing Nipro’s role as a strategic partner of Diaverum. The concept of “Value-Based-Care” resonates with both companies, who share

Diaverum welcomes M42 as its new shareholder

Diaverum is announcing today that M42 has entered into a definitive agreement to acquire 100% of the company from Bridgepoint.Diaverum, acquired by Bridgepoint in 2007, is a leading global renal care company that provides essential, life-sustaining dialysis treatments to patients in around 440 clinics across 23 countries worldwide. The company’s main focus is haemodialysis, in conjunction with a portfolio of treatments ranging from preventive care, peritoneal dialysis and home care to the coordination of patients’ comorbidities and their preparation for kidney transplantation. Diaverum